Public Benefit Corporation
Psilocybin already comes up in your intake room. A funded place for your clinicians to experience the program firsthand, and a legal, screened option for people who are not a fit for your protocol. The form takes about a minute; the call is thirty minutes, no obligation.
Brain functional connectivity on placebo (left) vs. psilocybin (right). Beckley Foundation / Imperial College London.
Psilocybin is converted to psilocin after ingestion, which binds to serotonin 5-HT2A receptors and produces downstream changes in brain network activity (Madsen et al., 2019). Three mechanisms are particularly relevant for clinicians:
The DMN is the brain network most associated with self-referential thinking, rumination, and the maintenance of rigid cognitive patterns. In depression and anxiety, the DMN becomes overactive, locking the brain into repetitive negative thought cycles that resist cognitive intervention. Psilocybin temporarily suppresses DMN activity, disrupting these patterns and increasing communication between brain regions that do not typically interact.
Psilocybin stimulates the release of Brain-Derived Neurotrophic Factor (BDNF) and promotes rapid dendritic spine growth in the prefrontal cortex. In preclinical research, a single dose produced measurable increases in the size and density of neuronal connections. This neuroplastic window, lasting days to weeks, represents a period of heightened capacity for behavioral and cognitive change.
Brain imaging from the Beckley Foundation / Imperial College London research program shows significantly increased functional connectivity under psilocybin, with thousands of new cross-network connections forming that are not present under placebo. This state is associated with increased psychological flexibility, emotional processing, and the capacity for insight.
Clinical implication: Clients may return from a psilocybin experience with access to new emotional, psychological, and somatic material that can reinvigorate the therapeutic process. The neuroplastic window following the experience is when therapeutic support can really help the process of transformation in the client's life.
Research cited in this content describes findings from independent studies and clinical trials, none of which describe Beckley Retreats' program. Findings reported in published research do not constitute claims by Beckley Retreats about its program, and Beckley Retreats does not represent that any individual will experience the outcomes described in the cited research.
"As a public health doctor with decades of global experience, I was deeply impressed by Beckley’s immersive, hands-on approach and their multidisciplinary team who mentored with warmth and wisdom. Their rare blend of deep wisdom, ethical integrity, and heartfelt connection laid an unforgettable foundation for my path as I deepened my path as a facilitator."
"Being immersed in Beckley’s retreat environment offered a rare blend of humility, attentiveness, and authentic human connection. It was a meaningful step in my development, guided by a team whose quiet strength and deep care left a lasting imprint."
“The Beckley Retreats practicum was the perfect culmination of my psychedelic practitioner training - rooted in science, tradition, and profound wisdom. What stayed with me most was the team’s extraordinary presence, which radiated trust, safety, and deep humanity.””
“This retreat was so profound and I am so grateful for the care and the intention with which the facilitators supported us. We showed up as strangers, but we felt as family members.”
"A few days after returning home I find myself back with my therapist again. I decide to read him an extract from my retreat journal and am transported back to my experience of my first trip again. When I finish I notice him wiping tears from his eyes. We're barely halfway through the session and, rather than feeling trapped behind a protective layer of ice, all I feel is warm."